Journal of Medicinal Chemistry
Article
(10) Liu, W. X.; Wang, R. Endomorphins: potential roles and
therapeutic indications in the development of opioid peptide analgesic
drugs. Med. Res. Rev. 2012, 32, 536−580.
homologation with concomitant peptide coupling. Structure determi-
nation by NMR and CD spectroscopy and by X-ray crystallography.
Helical secondary structure of a β-hexapeptide in solution and its
stability towards pepsin. Helv. Chim. Acta 1996, 79, 913−941.
(32) Appella, D. H.; Christianson, L. A.; Karle, I. L.; Powell, D. R.;
Gellman, S. H. β-Peptide foldamers: Robust helix formation in a new
family of β-amino acid oligomers. J. Am. Chem. Soc. 1996, 118, 13071−
13072.
(33) Steer, D. L.; Lew, R. A.; Perlmutter, P.; Smith, A. I.; Aguilar, M.
I. Beta-amino acids: versatile peptidomimetics. Curr. Med. Chem. 2002,
9, 811−822.
(34) Keresztes, A.; Szucs, M.; Borics, A.; Kover, K. E.; Forro, E.;
Fulop, F.; Tomboly, C.; Peter, A.; Pahi, A.; Fabian, G.; Muranyi, M.;
Toth, G. New endomorphin analogues containing alicyclic β-amino
acids: influence on bioactive conformation and pharmacological
profile. J. Med. Chem. 2008, 51, 4270−4279.
(35) Perlikowska, R.; Gach, K.; Fichna, J.; Toth, G.; Walkowiak, B.;
do-Rego, J. C.; Janecka, A. Biological activity of endomorphin and
[Dmt1]endomorphin analogs with six-membered proline surrogates in
position 2. Bioorg. Med. Chem. 2009, 17, 3789−3794.
(36) Staniszewska, R.; Fichna, J.; Gach, K.; Toth, G.; Poels, J.;
Vanden Broeck, J.; Janecka, A. Synthesis and biological activity of
endomorphin-2 analogs incorporating piperidine-2-, 3- or 4-carboxylic
acids instead of proline in position 2. Chem. Biol. Drug. Des. 2008, 72,
91−94.
(37) Torino, D.; Mollica, A.; Pinnen, F.; Lucente, G.; Feliciani, F.;
Davis, P.; Lai, J.; Ma, S. W.; Porreca, F.; Hruby, V. J. Synthesis and
evaluation of new endomorphin analogues modified at the Pro(2)
residue. Bioorg. Med. Chem. Lett. 2009, 19, 4115−4118.
(38) Frackenpohl, J.; Arvidsson, P. I.; Schreiber, J. V.; Seebach, D.
The outstanding biological stability of beta- and gamma-peptides
toward proteolytic enzymes: an in vitro investigation with fifteen
peptidases. ChemBioChem 2001, 2, 445−455.
(39) Cheng, R. P.; Gellman, S. H.; DeGrado, W. F. β-Peptides: From
structure to function. Chem. Rev. 2001, 101, 3219−3232.
(40) Spampinato, S.; Qasem, A. R.; Calienni, M.; Murari, G.;
Gentilucci, L.; Tolomelli, A.; Cardillo, G. Antinociception by a
peripherally administered novel endomorphin-1 analogue containing
beta-proline. Eur. J. Pharmacol. 2003, 469, 89−95.
(41) Wang, Y.; Xing, Y.; Liu, X.; Ji, H.; Kai, M.; Chen, Z.; Yu, J.;
Zhao, D.; Ren, H.; Wang, R. A new class of highly potent and selective
endomorphin-1 analogues containing α-methylene-β-aminopropanoic
acids (map). J. Med. Chem. 2012, 55, 6224−6236.
(42) Zhao, D. P.; Yang, D. X.; Wang, Y. J.; Wang, Y.; Mao, L. J.;
Wang, R. Enantioselective Mannich reaction of a highly reactive
Horner-Wadsworth-Emmons reagent with imines catalyzed by a
bifunctional thiourea. Chem. Sci. 2011, 2, 1918−1921.
(11) Keresztes, A.; Borics, A.; Toth, G. Recent advances in
endomorphin engineering. ChemMedChem 2010, 5, 1176−1196.
(12) Tomboly, C.; Peter, A.; Toth, G. In vitro quantitative study of
the degradation of endomorphins. Peptides 2002, 23, 1573−1580.
(13) Mentlein, R. Dipeptidyl-peptidase IV (CD26)–role in the
inactivation of regulatory peptides. Regul. Pept. 1999, 85, 9−24.
(14) Shane, R.; Wilk, S.; Bodnar, R. J. Modulation of endomorphin-2-
induced analgesia by dipeptidyl peptidase IV. Brain Res. 1999, 815,
278−286.
(15) Janecka, A.; Staniszewska, R.; Gach, K.; Fichna, J. Enzymatic
degradation of endomorphins. Peptides 2008, 29, 2066−2073.
(16) Cardillo, G.; Gentilucci, L.; Tolomelli, A. Unusual amino acids:
synthesis and introduction into naturally occurring peptides and
biologically active analogues. Mini-Rev. Med. Chem. 2006, 6, 293−304.
(17) Schwyzer, R. ACTH: a short introductory review. Ann. N.Y.
Acad. Sci. 1977, 297, 3−26.
(18) In, Y.; Minoura, K.; Ohishi, H.; Minakata, H.; Kamigauchi, M.;
Sugiura, M.; Ishida, T. Conformational comparison of mu-selective
endomorphin-2 with its C-terminal free acid in DMSO solution, by 1H
NMR spectroscopy and molecular modeling calculation. J. Pept. Res.
2001, 58, 399−412.
(19) Berezowska, I.; Chung, N. N.; Lemieux, C.; Wilkes, B. C.;
Schiller, P. W. Agonist vs antagonist behavior of δ opioid peptides
containing novel phenylalanine analogues in place of Tyr(1). J. Med.
Chem. 2009, 52, 6941−6945.
(20) Tomboly, C.; Ballet, S.; Feytens, D.; Kover, K. E.; Borics, A.;
Lovas, S.; Al-Khrasani, M.; Furst, Z.; Toth, G.; Benyhe, S.; Tourwe, D.
Endomorphin-2 with a β-turn backbone constraint retains the potent
μ-opioid receptor agonist properties. J. Med. Chem. 2008, 51, 173−
177.
(21) Janecka, A.; Kruszynski, R. Conformationally restricted peptides
as tools in opioid receptor studies. Curr. Med. Chem. 2005, 12, 471−
481.
(22) Janecka, A.; Staniszewska, R.; Fichna, J. Endomorphin analogs.
Curr. Med. Chem. 2007, 14, 3201−3208.
(23) Schiller, P. W. Bi- or multifunctional opioid peptide drugs. Life
Sci. 2010, 86, 598−603.
(24) Gentilucci, L.; Tolomelli, A. Recent advances in the
investigation of the bioactive conformation of peptides active at the
mu-opioid receptor. conformational analysis of endomorphins. Curr.
Top. Med. Chem. 2004, 4, 105−121.
(25) Hruby, V. J.; Balse, P. M. Conformational and topographical
considerations in designing agonist peptidomimetics from peptide
leads. Curr. Med. Chem. 2000, 7, 945−970.
(26) Hruby, V. J.; Porreca, F.; Yamamura, H. I.; Tollin, G.; Agnes, R.
S.; Lee, Y. S.; Cai, M.; Alves, I.; Cowell, S.; Varga, E.; Davis, P.;
Salamon, Z.; Roeske, W.; Vanderah, T.; Lai, J. New paradigms and
tools in drug design for pain and addiction. AAPS J. 2006, 8, E450−
460.
(27) Torino, D.; Mollica, A.; Pinnen, F.; Feliciani, F.; Lucente, G.;
Fabrizi, G.; Portalone, G.; Davis, P.; Lai, J.; Ma, S. W.; Porreca, F.;
Hruby, V. J. Synthesis and evaluation of new endomorphin-2
analogues containing (Z)-α,β-didehydrophenylalanine (δ(Z)Phe)
residues. J. Med. Chem. 2010, 53, 4550−4554.
(43) Li, T.; Fujita, Y.; Tsuda, Y.; Miyazaki, A.; Ambo, A.; Sasaki, Y.;
Jinsmaa, Y.; Bryant, S. D.; Lazarus, L. H.; Okada, Y. Development of
potent μ-opioid receptor ligands using unique tyrosine analogues of
endomorphin-2. J. Med. Chem. 2005, 48, 586−592.
(44) Liu, H. M.; Liu, X. F.; Yao, J. L.; Wang, C. L.; Yu, Y.; Wang, R.
Utilization of combined chemical modifications to enhance the blood-
brain barrier permeability and pharmacological activity of endomor-
phin-1. J. Pharmacol. Exp. Ther. 2006, 319, 308−316.
(45) Sasaki, Y.; Sasaki, A.; Niizuma, H.; Goto, H.; Ambo, A.
Endomorphin 2 analogues containing Dmp residue as an aromatic
amino acid surrogate with high mu-opioid receptor affinity and
selectivity. Bioorg. Med. Chem. 2003, 11, 675−678.
(46) Koda, Y.; Del Borgo, M.; Wessling, S. T.; Lazarus, L. H.; Okada,
Y.; Toth, I.; Blanchfield, J. T. Synthesis and in vitro evaluation of a
library of modified endomorphin 1 peptides. Bioorg. Med. Chem. 2008,
16, 6286−6296.
(47) Yabaluri, N.; Medzihradsky, F. Down-regulation of mu-opioid
receptor by full but not partial agonists is independent of G protein
coupling. Mol. Pharmacol. 1997, 52, 896−902.
(48) Liu, J. G.; Prather, P. L. Chronic agonist treatment converts
antagonists into inverse agonists at delta-opioid receptors. J.
Pharmacol. Exp. Ther. 2002, 302, 1070−1079.
(28) Giordano, C.; Sansone, A.; Masi, A.; Lucente, G.; Punzi, P.;
Mollica, A.; Pinnen, F.; Feliciani, F.; Cacciatore, I.; Davis, P.; Lai, J.;
Ma, S. W.; Porreca, F.; Hruby, V. Synthesis and activity of
endomorphin-2 and morphiceptin analogues with proline surrogates
in position 2. Eur. J. Med. Chem. 2010, 45, 4594−4600.
(29) Bryant, S. D.; Jinsmaa, Y.; Salvadori, S.; Okada, Y.; Lazarus, L.
H. Dmt and opioid peptides: a potent alliance. Biopolymers 2003, 71,
86−102.
(30) Schiller, P. W. Opioid peptide-derived analgesics. AAPS J. 2005,
7, E560−565.
(31) Seebach, D.; Overhand, M.; Kuhnle, F.; Martinoni, B.; Oberer,
̈
L.; Hommel, U.; Widmer, H. β-Peptides: Synthesis by Arndt-Eistert
3112
dx.doi.org/10.1021/jm400195y | J. Med. Chem. 2013, 56, 3102−3114